19 mayo 2015
A substantial percentage of patients with diabetic macular edema do not have high levels of the VEGF protein in the fluid inside their eyes but do have high levels of a protein called PKal (plasma kallikrein) and associated molecules that are key players in an inflammatory molecular pathway involved in the disease, research concludes. This finding, the researchers say, could lead to a new class of treatments to help preserve vision in these patients.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/lsHhy4KTFuc/150519122307.htm
